Vantive
Private Company
Funding information not available
Overview
Vantive is a Boston-based, private healthcare company founded in 2019, emerging from a long-standing legacy in kidney care. It operates at the intersection of medical devices, digital health, and services, offering therapies for chronic and acute kidney disease alongside extracorporeal organ support. The company's strategy centers on integrating digital solutions and advanced services with its core therapeutic devices to improve patient care and expand access, particularly to home-based dialysis. Vantive is in a commercial stage, generating revenue from its established portfolio while actively developing and launching new innovations.
Technology Platform
Integrated ecosystem of medical devices for dialysis and extracorporeal organ support, combined with digital health solutions (remote monitoring, data analytics, telehealth tools) and advanced service platforms.
Opportunities
Risk Factors
Competitive Landscape
Vantive competes directly with global dialysis giants Fresenius Medical Care and Baxter, as well as DaVita in clinic services. In acute organ support and digital health, it faces competition from other medtech players like Getinge and Asahi Kasei, as well as emerging digital therapy management platforms.